Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CKS1B | P61024 | 1/20 | 0.34 |
| ▸ | SKP1 | P63208 | 1/20 | 0.34 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14542900 | 0.89 | MAPT (0.36) | ALDH1A1MAPTTSHRGAAKMT2A | |
| SCHEMBL13295296 | 0.88 | MAPT (0.36) | ALDH1A1MAPTTSHRGAAKMT2A | |
| SCHEMBL23701708 | 0.84 | APP (0.39) | APPCYP1A2 | |
| SCHEMBL21678271 | 0.83 | APP (0.38) | APPCYP1A2 | |
| SCHEMBL14542899 | 0.80 | POLB (0.35) | ALDH1A1MAPTTSHRGAAKMT2A | |
| SCHEMBL14542762 | 0.80 | APP (0.35) | MAPTGAAKMT2ASMN1; SMN2APP | |
| SCHEMBL13043492 | 0.79 | PTGES (0.36) | ALDH1A1MAPTTSHRGAAMAPK1 | |
| SCHEMBL13295294 | 0.79 | KDM4E (0.35) | MAPTGAAKMT2ASMN1; SMN2APP | |
| SCHEMBL25171250 | 0.75 | APP (0.38) | GAAKMT2AAPPCYP1A2 | |
| SCHEMBL23675021 | 0.75 | APP (0.38) | GAAKMT2AAPPCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8206464-B2 | Blue polymeric hair dyes | BASF SE (DE) | 2012-06-26 | — | — | US | disclosed |
| US-20110061179-A1 | BLUE POLYMERIC HAIR DYES | BASF SE (US) | 2011-03-17 | — | — | US | disclosed |
| WO-2009090124-A1 | BLUE POLYMERIC HAIR DYES | BASF SE (DE) | 2009-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110061179-A1 | BLUE POLYMERIC HAIR DYES | CUTA, IK, TYR | ALDH1A1 2076/4885MAPT 657/4885TSHR 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.